SynthesisPharmacoEconomics2018

The Assessment for Disinvestment of Intramuscular Interferon Beta for Relapsing-Remitting Multiple Sclerosis in Brazil.

Livia Lovato Pires de Lemos et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.